Work

Abstract 4832: Preclinical evaluation of neratinib plus T-DM1 in orthotopic PDX models of HER2-positive breast cancer brain metastases

Year: 2019

Type: conference-abstract

Source: Experimental and Molecular Therapeutics

DOI: 10.1158/1538-7445.sabcs18-4832

Authors: Jing Ni, Yanzhi Wang, Irmina Diala, Sheheryar Kabraji, Rachel Freedman, Nancy Lin, Jean Zhao

Institutions: Dana-Farber Cancer Institute, Puma Biotechnology (United States)

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955877694

Cites:

Cited by:

Related to: 10